CYCC icon

Cyclacel Pharmaceuticals

16 hedge funds and large institutions have $307K invested in Cyclacel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$127K 210,700 +75,900 +56%
Vanguard Group
2
Vanguard Group
Pennsylvania
$69K 113,964 -262,933 -70%
RJFSA
3
Raymond James Financial Services Advisors
Florida
$30K 50,125
VF
4
Virtu Financial
New York
$22K 36,669 +23,676 +182%
PAM
5
Panagora Asset Management
Massachusetts
$16K 27,173 +9,733 +56%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$13K 21,692
Citadel Advisors
7
Citadel Advisors
Florida
$11K 18,124 +18,124 New
Northern Trust
8
Northern Trust
Illinois
$8K 13,399
UBS Group
9
UBS Group
Switzerland
$5K 8,093 +7,910 +4,322%
RE
10
RBC Europe
United Kingdom
$3.38K 5,586
Macquarie Group
11
Macquarie Group
Australia
$2K 2,900 +2,900 New
AIC
12
Ameritas Investment Company
Nebraska
$1K 1,747 +1,747 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
-32,369 Closed
TSS
14
Two Sigma Securities
New York
-13,980 Closed
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
-12,240 Closed
Bank of America
16
Bank of America
North Carolina
$0 179 -153 -46%
DOA
17
D'Orazio & Associates
Virginia
-100 Closed
SFM
18
Signet Financial Management
New Jersey
-23 Closed
Morgan Stanley
19
Morgan Stanley
New York
$0 108 -9 -8%
CFGS
20
Concourse Financial Group Securities
Alabama
BlackRock
21
BlackRock
New York
$0 796
Deutsche Bank
22
Deutsche Bank
Germany
$0 113 +113 New